ARVINAS, INC. ARVN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2018-09-27
ARVINAS, INC. institutional holders
| Investor | Shares | Value | % of company |
|---|---|---|---|
| BlackRock Finance, Inc. | 6,258,808 | $166.6M | 8.83% |
| D. E. Shaw & Co., Inc. | 3,495,153 | $29.0M | 4.93% |
| TWO SIGMA INVESTMENTS, LP | 2,573,447 | $21.4M | 3.63% |
| CITADEL ADVISORS LLC | 677,773 | $5.6M | 0.96% |
| AQR CAPITAL MANAGEMENT LLC | 601,873 | $5.0M | 0.85% |
| MILLENNIUM MANAGEMENT LLC | 574,011 | $4.8M | 0.81% |
| RENAISSANCE TECHNOLOGIES LLC | 215,345 | $1.8M | 0.3% |
| Point72 Asset Management, L.P. | 141,266 | $1.2M | 0.2% |
% of company = reported institutional shares ÷ shares outstanding. Based on the latest reports; not every holder reports every quarter.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.